Exalenz Bioscience (Israel) Valuation

EXEN -- Israel Stock  

ILS 624.10  6.50  1.05%

Exalenz Bioscience prevailing Real Value cannot be determined due to lack of data. The current price of Exalenz Bioscience is S624.1. Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Macroaxis computes value of Exalenz Bioscience from reviewing the firm fundamentals such as Operating Margin of (40.60)%, Shares Outstanding of 27.08M and Current Valuation of 173.65M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Not valued
April 26, 2019
Market Value
Real Value
Exalenz Bioscience is Unknown risk asset. Calculation of real value of Exalenz Bioscience is based on 2 months time horizon. Increasing Exalenz Bioscience time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Horizon     30 Days    Login   to change
Exalenz Bioscience Ltd is one of the top stocks in beta category among related companies. It is one of the top stocks in price to book category among related companies fabricating about  3,945  of Price to Book per Beta.
Additionally see Investing Opportunities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Search macroaxis.com